Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 32058843

Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low-Expressing Advanced Breast Cancer: Results From a Phase Ib Study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2020 Jun 10
First author
Modi S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer Discov. 2020 Apr;10(4):488. doi: 10.1158/2159-8290.CD-RW2020-030.
    note
    Source null
    related pmid
    32111601
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2020 Oct 1;38(28):3350-3351. doi: 10.1200/JCO.20.00657.
    note
    Source null
    related pmid
    32658628
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2020 Oct 1;38(28):3351-3352. doi: 10.1200/JCO.20.01212.
    note
    Source null
    related pmid
    32658630
    relationship
    Comment in

Authors and identifiers

  1. name
    Modi S
    type
    Author
  2. name
    Park H
    type
    Author
  3. name
    Murthy RK
    type
    Author
  4. name
    Iwata H
    type
    Author
  5. name
    Tamura K
    type
    Author
  6. name
    Tsurutani J
    type
    Author
  7. name
    Moreno-Aspitia A
    type
    Author
  8. name
    Doi T
    type
    Author
  9. name
    Sagara Y
    type
    Author
  10. name
    Redfern C
    type
    Author
  11. name
    Krop IE
    type
    Author
  12. name
    Lee C
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Modi S
    type
    Author
  2. name
    Park H
    type
    Author
  3. name
    Murthy RK
    type
    Author
  4. name
    Iwata H
    type
    Author
  5. name
    Tamura K
    type
    Author
  6. name
    Tsurutani J
    type
    Author
  7. name
    Moreno-Aspitia A
    type
    Author
  8. name
    Doi T
    type
    Author
  9. name
    Sagara Y
    type
    Author
  10. name
    Redfern C
    type
    Author
  11. name
    Krop IE
    type
    Author
  12. name
    Lee C
    type
    Author
bibliography ids
  1. nci-bib-4a59bba7f0cd4c7cc88a1a71
book metadata
content sha256
feb91f6d497847315d1580c7bae2d0e5d561e0035e9f9d93b114577fbd918650
document type
citation
dois
  1. 10.1200/JCO.19.02318
electronic publication date
display
2020 Feb 14
precision
day
year
2020
evidence scope
bibliographic_metadata_only
id
pubmed:32058843
immutable id
pubmed:32058843@feb91f6d497847315d1580c7bae2d0e5d561e0035e9f9d93b114577fbd918650
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
17
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1887-1896
volume
38
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer Discov. 2020 Apr;10(4):488. doi: 10.1158/2159-8290.CD-RW2020-030.
    note
    Source null
    related pmid
    32111601
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2020 Oct 1;38(28):3350-3351. doi: 10.1200/JCO.20.00657.
    note
    Source null
    related pmid
    32658628
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2020 Oct 1;38(28):3351-3352. doi: 10.1200/JCO.20.01212.
    note
    Source null
    related pmid
    32658630
    relationship
    Comment in
outcomes validated
false
pmid
32058843
provenance
batch id
4c5003fbb78890e89ae1
provider
NCBI PubMed ESummary
record sha256
113a14029c6b376d645ed020fed4205110d80155cfeadda7cf4e96a92cb8f7aa
response sha256
890389583ce193a9c74e19c63678e418dad2088e82cb704b888b02fcc887d269
retrieved at
2026-09-09T23:47:48.270700+00:00
publication date
display
2020 Jun 10
precision
day
year
2020
publication types
  1. Clinical Trial, Phase I
  2. Journal Article
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/32058843/
title
Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low-Expressing Advanced Breast Cancer: Results From a Phase Ib Study.

Preserved source evidence · Not medical advice